Kings Point Capital Management’s Clover Health Investments CLOV Stock Holding History

Kings Point Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$75K	Buy	21,000 +18,000	+600%	+$52.2K	0.01%	312
2021 Q4	$11K	Hold	3,000	–	–	﹤0.01%	618
2021 Q3	$22K	Buy	+3,000	New	+$25.7K	﹤0.01%	475

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kings Point Capital Management's CLOV Position: Q1 2022 in Review

Kings Point Capital Management increased its Clover Health Investments (CLOV) stake by 600% in Q1 2022, buying an estimated $52.2K and bringing the position to 21,000 shares worth $75K. The position accounts for 0.01% of the portfolio, ranked #312.

Kings Point Capital Management first reported a position in CLOV in Q3 2021 and has held it in 3 quarters since. 168 funds tracked by Wall St. Rank hold CLOV as of Q1 2022.

Kings Point Capital Management held 21,000 shares of Clover Health Investments worth $75K as of Q1 2022.
Kings Point Capital Management bought 18,000 Clover Health Investments shares in Q1 2022, an estimated $52.2K.
Clover Health Investments made up 0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #312 holding.
Kings Point Capital Management first reported a position in Clover Health Investments in Q3 2021 and has held it in 3 quarters since.
168 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.